PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Academic Department of Pediatrics (DPUO), Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.\', \'Chair of Pediatrics, Department of Systems Medicine, University of Rome \'Tor Vergata\', Rome, Italy.\', \'Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, Rome, Italy.\', \'PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.\', \'Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Occupational Medicine Unit, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Academic Department of Pediatrics (DPUO), Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Clinical Pathways and Epidemiology Unit-Medical Direction, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Medical Direction, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'Multimodal Medicine Research Area, Bambino Gesù Children\'s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.\', \'UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.727850
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34671350
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all